• Info
  • Insider Ownership

Insider Trading & Ownership of Kamil Ali-Jackson

Location
Malvern, PA
Summary
The estimated net worth of Kamil Ali-Jackson is at least $346,912 dollars as of 03 Mar 2026. Kamil Ali-Jackson is the Director of RIGEL PHARMACEUTICALS INC and owns shares of RIGEL PHARMACEUTICALS INC (RIGL) stock worth about $178.7K. Kamil Ali-Jackson is the Chief Legal Officer of Aclaris Therapeutics, Inc. and owns shares of Aclaris Therapeutics, Inc. (ACRS) stock worth about $168.2K.
Signature
/s/ Spencer Brown, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Kamil Ali-Jackson and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Kamil Ali-Jackson has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $346,912.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: RIGEL PHARMACEUTICALS INC ($178,687).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Kamil Ali-Jackson

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RIGL RIGEL PHARMACEUTICALS INC Director $178,687 23 May 2025
ACRS Aclaris Therapeutics, Inc. Chief Legal Officer $168,225 03 Jan 2022
PDSB PDS Biotechnology Corp Director 12 Jan 2026

Insider Transactions Reported by Kamil Ali-Jackson:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored